Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Mahfoud

Showing results (461-470 of 614) with videos related to

Pageof 62
Sort By:
Hypertension (Dallas, Tex. : 1979)|February 19, 2015
First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertensionMichael Böhm, Felix Mahfoud, Christian Ukena, et al.
Circulation. Cardiovascular Interventions|April 12, 2022
Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 TrialBruno Scheller, Tuomas T Rissanen, Ahmed Farah, et al.
International Journal of Cardiology. Heart & Vasculature|May 15, 2025
Pulsed-field ablation versus cryoballoon ablation in patients with persistent atrial fibrillationCorinne Isenegger, Rebecca Arnet, Fabian Jordan, et al.
European Heart Journal|January 5, 2019
Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trialMichael Böhm, Felix Mahfoud, Raymond R Townsend, et al.
Journal of Hypertension|November 3, 2016
Renal denervation reduces office and ambulatory heart rate in patients with uncontrolled hypertension: 12-month outcomes from the global SYMPLICITY registryMichael Böhm, Christian Ukena, Sebastian Ewen, et al.
Journal of the American College of Cardiology|March 7, 2020
Survival After Coronary Revascularization With Paclitaxel-Coated BalloonsBruno Scheller, Davor Vukadinovic, Raban Jeger, et al.
Heart Rhythm|July 3, 2026
Pulsed-Field Ablation with Two Different-Sized Pentaspline Catheters in Patients with Atrial FibrillationCorinne Isenegger, Behnam Subin, Jonas Brügger, et al.
Lancet (London, England)|April 10, 2017
Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trialsMichael Böhm, Helmut Schumacher, Koon K Teo, et al.
Hypertension (Dallas, Tex. : 1979)|April 25, 2024
Artificial Intelligence-Derived Risk Prediction: A Novel Risk Calculator Using Office and Ambulatory Blood PressurePedro Guimarães, Andreas Keller, Michael Böhm, et al.
Journal of the American College of Cardiology|September 3, 2021
Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled HypertensionMichael Böhm, Konstantinos Tsioufis, David E Kandzari, et al.
Pageof 62

Showing results (461-470 of 614) with videos related to

Sort By:
Pageof 62
Hypertension (Dallas, Tex. : 1979)|February 19, 2015
First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertensionMichael Böhm, Felix Mahfoud, Christian Ukena, et al.
Circulation. Cardiovascular Interventions|April 12, 2022
Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 TrialBruno Scheller, Tuomas T Rissanen, Ahmed Farah, et al.
International Journal of Cardiology. Heart & Vasculature|May 15, 2025
Pulsed-field ablation versus cryoballoon ablation in patients with persistent atrial fibrillationCorinne Isenegger, Rebecca Arnet, Fabian Jordan, et al.
European Heart Journal|January 5, 2019
Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trialMichael Böhm, Felix Mahfoud, Raymond R Townsend, et al.
Journal of Hypertension|November 3, 2016
Renal denervation reduces office and ambulatory heart rate in patients with uncontrolled hypertension: 12-month outcomes from the global SYMPLICITY registryMichael Böhm, Christian Ukena, Sebastian Ewen, et al.
Journal of the American College of Cardiology|March 7, 2020
Survival After Coronary Revascularization With Paclitaxel-Coated BalloonsBruno Scheller, Davor Vukadinovic, Raban Jeger, et al.
Heart Rhythm|July 3, 2026
Pulsed-Field Ablation with Two Different-Sized Pentaspline Catheters in Patients with Atrial FibrillationCorinne Isenegger, Behnam Subin, Jonas Brügger, et al.
Lancet (London, England)|April 10, 2017
Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trialsMichael Böhm, Helmut Schumacher, Koon K Teo, et al.
Hypertension (Dallas, Tex. : 1979)|April 25, 2024
Artificial Intelligence-Derived Risk Prediction: A Novel Risk Calculator Using Office and Ambulatory Blood PressurePedro Guimarães, Andreas Keller, Michael Böhm, et al.
Journal of the American College of Cardiology|September 3, 2021
Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled HypertensionMichael Böhm, Konstantinos Tsioufis, David E Kandzari, et al.
Pageof 62